Research
What a registered clinical trial tells you
An NCT number on a product page proves that someone filled in a form. Registration records what a study intends to do, and it is written by the sponsor rather than checked by anyone.
What registration is
ClinicalTrials.gov is a public registry run by the National Library of Medicine. A sponsor submits a record describing a planned or ongoing study and receives an identifier, the NCT number.
The record is self-reported. It states who is running the study, what will be given, to whom, how many people, and what will be measured. Nobody reviews the science before it goes up, because that is not what a registry does.
Registration is real and it is useful. It creates a public commitment to what a study set out to do, which is what makes selective reporting detectable later. It is not a stamp of approval and it is not a result.
The distance between registered and reported
The registry marks whether results have been posted, and the gap is measurable.
In a September 2026 census, aspirin returned 2,181 registered studies, of which 339 carry posted results and 1,842 do not. Semaglutide returned 748, of which 107 carry results and 641 do not. Both partitions add exactly to the total, which is how the filter itself was checked before any zero below was reported.
Against those controls, BPC-157 returned four registered studies and MOTS-c returned five. Neither compound has a single record with results posted. KPV and Epitalon returned no registered studies at all, and a nonsense search term returned zero through every query in the same session.
So a product page pointing at registered trials for these compounds is pointing at intentions. The reporting half of the record is empty.
When results are actually required
Federal regulation requires results for a defined subset of studies, called applicable clinical trials, not for everything in the registry.
For those studies, results information must be submitted no later than one year after the primary completion date. A sponsor seeking approval, licensure or clearance of a new use can certify for a delay, which is a documented exception rather than a loophole.
Registration itself is required for any applicable clinical trial initiated after September 27, 2007. Records are also submitted voluntarily by sponsors of studies that fall outside the requirement, and those carry no results obligation at all.
The practical consequence is that "no results posted" can mean the deadline has not arrived, the study is not covered by the rule, or the sponsor did not comply. The registry does not distinguish among them for you.
Reading the status field
The registry uses a fixed status vocabulary, and several of the values are commonly misread as progress.
Not yet recruiting means nobody has been enrolled. Recruiting means enrollment is open. Active, not recruiting means enrollment closed while follow-up continues.
Completed means the study finished, which is not the same as results being available. Terminated, suspended and withdrawn each describe a study that stopped, and withdrawn means it stopped before enrolling anyone.
Unknown status is the one worth pausing on, and the registry defines it precisely. It applies to a study whose last known status was recruiting, not yet recruiting, or active and not recruiting, that has passed its completion date and has not been verified within the past two years. Under federal regulation, recruitment status must be updated within 30 days of a change and registration information at least once every 12 months, so an unknown record is one whose sponsor went quiet.
A page citing an ongoing trial should be checked against the status field. "Ongoing" and "registered in 2016 and never updated" look identical in a footnote.
What five registered studies can contain
A count of registry hits is not a count of studies of the intervention, and MOTS-c shows why.
The five records returned in September 2026 include a phase 2 study of MOTS-c for insulin sensitivity in adults with prediabetes, which is a study of the compound. The other four are not.
One compares two forms of anesthesia. One studies the cardiovascular effects of a GLP-1 agonist and an SGLT2 inhibitor. One is a screening cohort of tens of thousands of people for deafness genes. Those studies measure MOTS-c as one marker among many.
The registry search matches any study naming the term as an intervention or measure, which is the right behavior for a registry and the wrong number to quote as a study count.
BPC-157 shows a milder version. Of its four records, one is a completed study of peptide gummies, two are unstarted or recruiting surgical and muscle-injury studies, and one has sat at unknown status since it was registered.
Phase is a design label, not a ranking
Phase 1 studies are typically small and focused on safety and how the body handles a drug. Phase 2 looks for a signal of effect. Phase 3 is the large comparison that supports an approval application.
Records also carry the value "not applicable", which is used for studies that are not drug trials in the regulatory sense, including many behavioral, device and supplement studies.
A phase label describes what a study was designed to do. It does not describe how well it was done, and it does not mean the study happened. A registered phase 2 that never enrolled anyone is still labeled phase 2.
How to check a citation in about a minute
Take the NCT number and open the record. Read the status first, then whether results are posted, then the enrollment number and whether it is actual or anticipated.
Read the intervention field and confirm the compound is being given rather than measured. Read the sponsor. A study run by the seller is not disqualifying, and it is worth knowing.
Then compare the population, the route and the condition against the way the product is sold to you. A registered study in one population, by one route, for one condition is evidence about that combination and nothing wider.
If a page names a trial without an NCT number, the record cannot be checked, and an unverifiable citation is worth exactly as much as no citation.
Key takeaways
- A registry record is written by the sponsor and reviewed by nobody before it appears.
- In a September 2026 census, BPC-157 had four registered studies and MOTS-c five, none with posted results.
- Aspirin returned 2,181 registered studies with 339 carrying results, the control those zeros are reported against.
- Results are required within one year of primary completion only for studies covered by the federal rule.
- Four of the five MOTS-c records study anesthesia, cardiovascular drugs or genetic screening, not the peptide.
- Unknown status means a sponsor stopped updating the record, not that a study succeeded or failed.
Frequently asked questions
Does an NCT number mean a peptide has been tested?
It means a study record exists. Registration is self-reported by the sponsor and no one reviews the science before it appears. The record may describe a study that has not enrolled anyone, stopped early, or finished years ago without posting results. Open the record and read the status, the enrollment figure and whether results are posted before treating it as evidence.
Why do so many registered studies have no results?
Because the reporting requirement covers a defined subset called applicable clinical trials, and for those the deadline is one year after the primary completion date. Studies outside that subset carry no obligation. Non-compliance also happens. The registry marks whether results are posted but does not tell you which of those three explanations applies, so the absence has to be read alongside the status and completion dates.
How many registered trials do BPC-157 and MOTS-c have?
A September 2026 census returned four for BPC-157 and five for MOTS-c, and none of the nine has posted results. Reading the records matters more than the counts: four of the five MOTS-c records are studies of anesthesia, cardiovascular drugs and a genetic screening cohort that measure the peptide as a marker. In the same session, aspirin returned 2,181 registered studies with 339 carrying results, which is the control those zeros are reported against.
What does "unknown status" mean on a trial record?
That the record passed its expected completion date without being updated. Under federal regulation, recruitment status has to be updated within 30 days of a change and registration information at least annually, so an unknown record is one whose sponsor stopped maintaining it. It is not evidence a study failed, and it is not evidence a study is running.
Is a phase 2 trial better evidence than a phase 1?
It is a different design, aimed at a different question. Phase 1 focuses on safety and how the body handles a drug. Phase 2 looks for a signal of effect in a small group. Phase 3 is the large comparison behind an approval application. A later phase is not a guarantee of quality, and a registered phase says only what a study intended to be, not what it delivered.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- ClinicalTrials.gov registered-study census for BPC-157, MOTS-c, KPV and Epitalon, with aspirin and semaglutide as controls through the identical query — ClinicalTrials.gov, National Library of Medicine, September 2026
- ClinicalTrials.gov API study status vocabulary — ClinicalTrials.gov, National Library of Medicine, September 2026
- ClinicalTrials.gov API field metadata, including the definition of Unknown Status — ClinicalTrials.gov, National Library of Medicine, September 2026
- 42 CFR 11.44 — When clinical trial results information must be submitted — Office of the Federal Register, eCFR, September 2026
- 42 CFR 11.22 — Which applicable clinical trials must be registered — Office of the Federal Register, eCFR, September 2026
- 42 CFR 11.64 — When submitted clinical trial information must be updated or corrected — Office of the Federal Register, eCFR, September 2026